Gastric & Breast Cancer e-journal
Online First. DOI: 10.2122/gbc.2011.0168
REVIEW
|
Selecting robotic and laparoscopic surgery in surgical oncology: fast progress but need for evidence. |
Prof. Dr. Med Christof Hottenrott, M.D.
|
Affiliation: Prof. Dr. Med Christof Hottenrott, Chirurgische Klinik St. Elisabethenkrankenhaus Ginnheimer Straße 3, 60487, Frankfurt, Germany.
|
ABSTRACT
Although there is no evidence for improving overall survival, comparative-effectiveness research indicates better short-term outcome and quality-of-life with minimally invasive surgery than open surgery for specific cancer types. For example, laparoscopic colectomy has been the standard for colon cancer in specialized hospital. Positive results are also reported recently for laparoscopic resections of rectal and gastric cancer that may also replace open surgery in the next years. Latest advances include the use of robots as the Da Vinci Surgical System and single-incision minimally invasive techniques. Robotic surgery with prostatectomy and low anterior rectum resection is increasingly now used in the treatment of prostate and rectal cancer. Here I discuss the advances, limitations and opportunities to overcome challenges for future establishment of robotic and laparoscopic surgery for specific tumor locations personalizing surgical decisions in the treatment of solid cancers.
(Citation: Gastric & Breast Cancer 2011; 10(3): 192-199)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €33 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
